Evidence map›Paper›PMID 24174443›Full record

ReviewILAR journal2013

Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Anthony W S Chan

Open access · bronzeAbstract readReview
In one paragraph

Review in ILAR journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Seasonal Prevalence of Gastrointestinal Parasites in Macaques (Animals : an open access journal from MDPI · 2022
    Article
  10. Article
  11. Zoological research · 2021
    Article
  12. Review
  13. Article
  14. Nonhuman Primate Optogenetics: Current Status and Future Prospects.Advances in experimental medicine and biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 2 countries.

Anthony W S Chan
Emory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Establishment of a transgenic monkey of Huntingtons's dieseaseR24RR018827 · NCRR · EMORY UNIVERSITY · PI CHAN, ANTHONY WING SANG · 2004 to 2011
$6.2M
Transgenic Huntington's disease monkey resourceR24OD010930 · OD · EMORY UNIVERSITY · PI CHAN, ANTHONY WING SANG · 2012 to 2018
$6.1M
MONITORING STEM CELL GRAFTS USING A NOVEL MRI REPORTERR01NS064991 · NINDS · EMORY UNIVERSITY · PI CHAN, ANTHONY WING SANG · 2009 to 2012
$1.5M
NCRR NIH HHS ORIP/NIH RR018827NCRR NIH HHS P51RR165NCRR NIH HHS R24 RR018827NIH HHS (ORIP)/OD P51OD11132NIH HHS P51 OD011132NIH HHS R24 OD010930NINDS NIH HHS NS064991NINDS NIH HHS R01 NS064991
6 · The paper itself

Abstract

The growing interest of modeling human diseases using genetically modified (transgenic) nonhuman primates (NHPs) is a direct result of NHPs (rhesus macaque, etc.) close relation to humans. NHPs share similar developmental paths with humans in their anatomy, physiology, genetics, and neural functions; and in their cognition, emotion, and social behavior. The NHP model within biomedical research has played an important role in the development of vaccines, assisted reproductive technologies, and new therapies for many diseases. Biomedical research has not been the primary role of NHPs. They have mainly been used for safety evaluation and pharmacokinetics studies, rather than determining therapeutic efficacy. The development of the first transgenic rhesus macaque (2001) revolutionized the role of NHP models in biomedicine. Development of the transgenic NHP model of Huntington's disease (2008), with distinctive clinical features, further suggested the uniqueness of the model system; and the potential role of the NHP model for human genetic disorders. Modeling human genetic diseases using NHPs will continue to thrive because of the latest advances in molecular, genetic, and embryo technologies. NHPs rising role in biomedical research, specifically pre-clinical studies, is foreseeable. The path toward the development of transgenic NHPs and the prospect of transgenic NHPs in their new role in future biomedicine needs to be reviewed. This article will focus on the advancement of transgenic NHPs in the past decade, including transgenic technologies and disease modeling. It will outline new technologies that may have significant impact in future NHP modeling and will conclude with a discussion of the future prospects of the transgenic NHP model.

Indexed as

Disease Models, AnimalAnimalsAnimals, Genetically ModifiedGenetic Diseases, InbornGene Transfer TechniquesHumansMacacaanimal modelhuman diseasesnonhuman primatestransgenesis

Identifiers

PMID24174443
PMCPMC3814401
OpenAlexW2103350863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.